Clinical Studies

We are looking for hospitals to participate in a new clinical trial for dogs with diarrhea.

Arkus MB is a novel live probiotic product which consists of 3 bacterial species that are typically found in the gut of healthy dogs: Clostridium hiranonis, Megamonas funiformis, and Enterococcus faecium. These bacteria were selected based on an extensive GI microbiome sequencing survey and analysis that compared differences between healthy dogs and those with GI issues. This study now seeks to evaluate the ability of this probiotic to resolve diarrhea in dogs.

Eligible patients meet the following criteria:

• Adult dogs 1+ years old.
• Dogs with diarrhea of any duration. Small bowel diarrhea, large bowel diarrhea, or mixed. Purina fecal score 4-7.
• No hemorrhagic diarrhea <7 days’ duration.
• No diet change in the previous 30 days.
• No systemic antibiotics for 1 week prior to study enrollment.
• No Intestinal parasites or Giardia infection identified on screening testing.

The study duration is 56 days, including 3 study visits (see study schedule below):

Owner incentive: No cost for exams and all diagnostics associated with the study (~$1,500 value)!

Interested?

Enroll or request more information below